PIRAMAL PHARMA
|
The Current P/S Ratio of PIRAMAL PHARMA is 2.41.
Share Price | ₹149.0 | May 14,2024 |
Market Cap | ₹19,711.2 Cr | |
Sales-TTM | ₹8,171.2 Cr | TTM-Consolidated Results |
Price/Sales | 2.41x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of PIRAMAL PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹19,711.2 Cr] as on May 14,2024
(/) Sales [ ₹8,171.2 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.41x ]
Thus, for PIRAMAL PHARMA , the investors are currently willing to pay '2.41 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of PIRAMAL PHARMA !
The chart below summarizes the trend in P/S Ratio of PIRAMAL PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of PIRAMAL PHARMA
PS Ratio Performance Analysis for PIRAMAL PHARMA
- PIRAMAL PHARMA 's p/e ratio for fiscal years ending Mar2023 to Mar2021 averaged 0.38x.
- PIRAMAL PHARMA 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 3 fiscal years, PIRAMAL PHARMA 's p/e ratio peaked in Mar2023 at 1.15x.
- PIRAMAL PHARMA 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does PIRAMAL PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
PIRAMAL PHARMA | 8,171.2 | 2.41 | 19,711.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 47,444.6 | 7.81 | 370,757.0 |
CIPLA LTD | 25,774.1 | 4.25 | 109,559.0 |
DR REDDYS LABORATORIES LTD | 28,011.1 | 3.50 | 97,939.0 |
ZYDUS LIFESCIENCES LTD | 19,024.2 | 5.21 | 99,088.9 |
DIVIS LABORATORIES LTD | 7,492.8 | 13.80 | 103,416.0 |
MANKIND PHARMA LTD | 9,946.3 | 9.05 | 90,040.7 |
TORRENT PHARMACEUTICALS LTD | 10,474.0 | 8.50 | 89,016.2 |
LUPIN LTD | 20,010.8 | 3.73 | 74,572.1 |
AUROBINDO PHARMA LTD | 27,894.7 | 2.45 | 68,346.8 |
ABBOTT INDIA LTD | 5,848.9 | 9.73 | 56,915.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs PIRAMAL PHARMA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.41x |
Max industry PS | 13.80x |
Median industry PS | 5.21x |
Average industry PS | 6.40x |
You may also like the below Video Courses